From Names to Numbers: Deconstructing Two 2025 Council on Therapeutics Policies

Broadcast Date: October 14, 2025

ABOUT THIS PODCAST

Members of the Council on Therapeutics unpack two ASHP policies adopted in the 2025 House of Delegates— one addressing the FDA’s proposal to change drug naming conventions, and the other requiring height and weight on certain medication orders. They share why these policies matter, the challenges encountered during the policy process, and the improvements they hope to see in patient care as a result.

SHOW NOTES

ASHP Policy Positions 1982-2025

SPEAKERS

Monica Mehta, PharmD, MPH
Director, Policy Planning, ASHP
Kunal Patel, PharmD, MBA, BCPS
Pharmacy Operations Manager, Emory University Hospital
Martha Roberts, PharmD, BCCCP
Pharmacy Department Coordinator, Brown University Health
Rachel Meyers, PharmD, BCPS
Clinical Pharmacist Specialist in Pediatrics, Professor, Rutgers University

LISTEN ON

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Pharmacy Futures 2024

Welcome to our new format!

Start Here

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management

Learn More